Hilde De Winter

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

Marie Scully, Spero R. Cataland, Flora Peyvandi et al. · New England Journal of Medicine · 2019 · 999 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura

Flora Peyvandi, Marie Scully, Johanna A. Kremer Hovinga et al. · Journal of Thrombosis and Haemostasis · 2017 · 133 citations · Full text

Medicine, Hematology, Pharmacology +13

NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14<i>i</i> NKT Cells

Dirk Elewaut, Raziya B. Shaikh, Kirsten J. L. Hammond et al. · The Journal of Experimental Medicine · 2003 · 116 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: A prospective study in 144 consecutive patients

J. Verbanck, Ignace Vandewiele, Hilde De Winter et al. · Journal of Clinical Ultrasound · 1997 · 88 citations

Medicine, Oncology, Radiology +16

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

Flora Peyvandi, Spero R. Cataland, Marie Scully et al. · Blood Advances · 2021 · 80 citations · Full text

Medicine, Hematology, Pharmacology +7